Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting

The COVID-19 pandemic is having an important impact on the practice of mental health services and on schizophrenia patients, and heterogeneous and conflicting findings are being reported on the reduction of long-acting injectable (LAI) antipsychotics use. Aims of the study were to assess the total n...

Descripción completa

Detalles Bibliográficos
Autores principales: Barlati, Stefano, Nibbio, Gabriele, Bianchi, Francesco, Gigli, Elena Butti Lemmi, Calzavara-Pinton, Irene, Cerati, Caterina, Fiori, Jacopo, Lisoni, Jacopo, Deste, Giacomo, Vita, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526678/
https://www.ncbi.nlm.nih.gov/pubmed/36206591
http://dx.doi.org/10.1016/j.psychres.2022.114878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526678/
https://www.ncbi.nlm.nih.gov/pubmed/36206591
http://dx.doi.org/10.1016/j.psychres.2022.114878

Ejemplares similares